KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exact Sciences (EXAS) EBIT: 2009-2025

Historic EBIT for Exact Sciences (EXAS) over the last 17 years, with Sep 2025 value amounting to -$25.5 million.

  • Exact Sciences' EBIT rose 35.17% to -$25.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.0 billion, marking a year-over-year decrease of 316.35%. This contributed to the annual value of -$1.0 billion for FY2024, which is 387.74% down from last year.
  • Exact Sciences' EBIT amounted to -$25.5 million in Q3 2025, which was down 1,089.25% from -$2.1 million recorded in Q2 2025.
  • Over the past 5 years, Exact Sciences' EBIT peaked at $6.8 million during Q3 2023, and registered a low of -$876.4 million during Q4 2024.
  • For the 3-year period, Exact Sciences' EBIT averaged around -$126.1 million, with its median value being -$67.8 million (2023).
  • In the last 5 years, Exact Sciences' EBIT spiked by 104.96% in 2023 and then slumped by 1,191.77% in 2024.
  • Quarterly analysis of 5 years shows Exact Sciences' EBIT stood at -$221.4 million in 2021, then skyrocketed by 46.32% to -$118.9 million in 2022, then soared by 42.93% to -$67.8 million in 2023, then plummeted by 1,191.77% to -$876.4 million in 2024, then surged by 35.17% to -$25.5 million in 2025.
  • Its last three reported values are -$25.5 million in Q3 2025, -$2.1 million for Q2 2025, and -$96.0 million during Q1 2025.